Co-processed excipients

Co-processed excipients may enhance functionality and reduce drawbacks of traditional excipients for the manufacture of tablets on a commercial scale....

This article aims to compare three commercially available co-processed excipients (CPEs), namely the F-Melts® type C,M and F1. All three...

Introduction Polymers have various applications such as binder, film coating agent, stabilizer, drug release modification and as primary packaging materials....

The formulation of orodispersible minitablets (ODMTs) usually targets the disintegration time and mechanical strength, but should also consider a series...

HiSORAD is a state-of-the-art co-processed excipient for orally disintegrating tablets designed to have well-balanced property between orally disintegration time and...

Sulpiride (SUL) is a dopamine D2-receptor antagonist used for management of GIT disturbance and it has anti-psychotic activities based on...

Mini-tablets are solid dosage forms with increasing interest for pharmaceutical industry due to clinical and biopharmaceutical benefits. But technological aspects...

MEGGLE released the new excipient Reta M® at October 13. Pharma Excipients used the chance to do an interview with...

Multiple-unit pellet systems (MUPS) oer many advantages over conventional solid dosage forms both for the manufacturers and patients. Coated pellets...

This article aims to compare three commercially available co-processed excipients (CPEs), namely the F-Melt® type C, M and F1. All...